ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04612	Antigen processing and presentation	16/147	77/7206	1.86268708979e-12
ko05340	Primary immunodeficiency	11/147	30/7206	6.85243506049e-12
ko05164	Influenza A	21/147	167/7206	1.52823910475e-11
ko05320	Autoimmune thyroid disease	10/147	29/7206	1.32032609507e-10
ko04060	Cytokine-cytokine receptor interaction	21/147	191/7206	2.0167570951e-10
ko05330	Allograft rejection	9/147	24/7206	4.82384531996e-10
ko05168	Herpes simplex infection	20/147	182/7206	5.72399539215e-10
ko05162	Measles	16/147	120/7206	2.00248659985e-09
ko05152	Tuberculosis	19/147	187/7206	6.03007622832e-09
ko05321	Inflammatory bowel disease (IBD)	11/147	56/7206	1.18570925333e-08
ko05145	Toxoplasmosis	15/147	126/7206	3.18208023146e-08
ko05332	Graft-versus-host disease	7/147	18/7206	3.36107930369e-08
ko04672	Intestinal immune network for IgA production	9/147	37/7206	3.66117697597e-08
ko05140	Leishmaniasis	11/147	75/7206	2.79851103529e-07
ko04650	Natural killer cell mediated cytotoxicity	12/147	97/7206	5.3295519069e-07
ko04621	NOD-like receptor signaling pathway	15/147	157/7206	5.98727989743e-07
ko04145	Phagosome	15/147	162/7206	8.9751087663e-07
ko04659	Th17 cell differentiation	12/147	106/7206	1.40572590664e-06
ko04940	Type I diabetes mellitus	7/147	32/7206	2.79745637463e-06
ko04658	Th1 and Th2 cell differentiation	11/147	96/7206	3.49136587495e-06
ko04620	Toll-like receptor signaling pathway	11/147	100/7206	5.22882505497e-06
ko05150	Staphylococcus aureus infection	7/147	36/7206	6.4796251992e-06
ko05161	Hepatitis B	14/147	173/7206	1.0330812656e-05
ko03050	Proteasome	8/147	54/7206	1.16589130975e-05
ko05323	Rheumatoid arthritis	10/147	89/7206	1.17776907166e-05
ko05416	Viral myocarditis	8/147	55/7206	1.34104094089e-05
ko05310	Asthma	5/147	17/7206	1.67587345732e-05
ko04660	T cell receptor signaling pathway	11/147	124/7206	4.10681230013e-05
ko05133	Pertussis	9/147	87/7206	6.34140244102e-05
ko04217	Necroptosis	13/147	178/7206	6.39284038614e-05
ko04622	RIG-I-like receptor signaling pathway	7/147	62/7206	0.000245118858167
ko05144	Malaria	6/147	45/7206	0.000274990628763
ko04514	Cell adhesion molecules (CAMs)	10/147	130/7206	0.000302541272396
ko04630	Jak-STAT signaling pathway	10/147	132/7206	0.000342303117708
ko05167	Kaposi's sarcoma-associated herpesvirus infection	12/147	191/7206	0.000500055278333
ko04064	NF-kappa B signaling pathway	8/147	96/7206	0.000722280626875
ko04062	Chemokine signaling pathway	12/147	201/7206	0.000788768627833
ko05160	Hepatitis C	10/147	153/7206	0.00109333386902
ko04380	Osteoclast differentiation	9/147	134/7206	0.00160245438257
ko04640	Hematopoietic cell lineage	6/147	64/7206	0.00184273458684
ko04610	Complement and coagulation cascades	6/147	79/7206	0.00532458683132
ko05131	Shigellosis	6/147	82/7206	0.00638241900473
ko05166	HTLV-I infection	13/147	292/7206	0.00863401888592
ko04623	Cytosolic DNA-sensing pathway	4/147	41/7206	0.00937394184822
ko04666	Fc gamma R-mediated phagocytosis	7/147	122/7206	0.0121314436141
ko05132	Salmonella infection	6/147	98/7206	0.0147325811004
ko05146	Amoebiasis	6/147	99/7206	0.0154271214319
ko04144	Endocytosis	14/147	342/7206	0.0159811629045
ko05142	Chagas disease (American trypanosomiasis)	7/147	130/7206	0.0167371539469
ko04611	Platelet activation	8/147	163/7206	0.0180934628488
ko04210	Apoptosis	8/147	180/7206	0.0305567636595
ko05322	Systemic lupus erythematosus	7/147	151/7206	0.0344527802548
ko05020	Prion diseases	3/147	40/7206	0.0474591765945